4.5 Article

Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea

Related references

Note: Only part of the references are listed.
Article Immunology

Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study

Jessica Seessle et al.

Summary: Long COVID, defined as persistent symptoms after SARS-CoV-2 infection, can last for at least 1 year and significantly impact life quality. Neurocognitive symptoms, possibly related to autoimmunity indicated by elevated ANA titers, are more common in females and can persist even when SARS-CoV-2 antibody levels are not significantly different from patients without symptoms.

CLINICAL INFECTIOUS DISEASES (2022)

Editorial Material Anesthesiology

The 'third wave': impending cognitive and functional decline in COVID-19 survivors

Hanan A. Baker et al.

BRITISH JOURNAL OF ANAESTHESIA (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Article Biochemistry & Molecular Biology

Attributes and predictors of long COVID

Carole H. Sudre et al.

Summary: Reports on long-lasting COVID-19 symptoms, known as 'long COVID', are increasing. Analysis of data from over 4,000 COVID-19 cases revealed that long COVID is more common in older individuals, those with higher body mass index, and females. Experiencing more than five symptoms in the first week of illness was associated with long COVID. A simple model showed promise in distinguishing between short and long COVID cases early in the disease.

NATURE MEDICINE (2021)

Review Psychiatry

Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review

Yazen Alnefeesi et al.

Summary: The prevalence and etiology of cognitive impairment in COVID-19 patients, especially in relation to inflammation and cytokine storms, indicate a significant impact on brain health. High rates of cognitive deficits, primarily delirium, are reported, with inflammatory markers potentially playing a crucial role in mediating these impairments.

FRONTIERS IN PSYCHIATRY (2021)

Article Infectious Diseases

'Long COVID': persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria

Bodunrin Osikomaiya et al.

Summary: The study found that over one-third of COVID-19 survivors experience persistent symptoms after discharge, with common symptoms being fatigue, headaches, and chest pain. The severity of symptomatic COVID-19 disease may predict the presence of these persistent symptoms.

BMC INFECTIOUS DISEASES (2021)

Article Clinical Neurology

Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables

K. W. Miskowiak et al.

Summary: This study investigated the frequency, pattern, and severity of cognitive impairments in patients 3-4 months after COVID-19 hospital discharge, finding that a majority of patients had clinically significant cognitive impairment. These impairments were associated with subjective cognitive complaints, lower quality of life, and illness variables. Further research is needed to understand the associations between cognitive sequelae of COVID-19 and lung affection, cerebral oxygen delivery, and targeted treatments for persistent cognitive impairments.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)

Review Infectious Diseases

Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review

Eleni Korompoki et al.

Summary: Long COVID, characterized by persistent or new symptoms in COVID-19 survivors, can involve all body systems and have a negative impact on mental health and quality of life. Despite unclear pathogenesis, early recognition and thorough follow-up are essential for holistic treatment of survivors.

JOURNAL OF INFECTION (2021)

Article Geriatrics & Gerontology

Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19

M. M. Walle-Hansen et al.

Summary: More than half of the patients reported a negative change in HR-QoL 6 months following hospitalisation due to COVID-19, and one out of three experienced a persistently impaired mobility and ability to carry out activities of daily living. The results suggest awareness of long-term functional decline in older COVID-19 patients.

BMC GERIATRICS (2021)

Review Medicine, General & Internal

Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge

Domenico Nuzzo et al.

Summary: The emergence of the highly pathogenic coronavirus SARS-CoV-2 in China in December 2019 led to the global spread of COVID-19, causing devastating socio-economic impacts and necessitating a focus on vulnerable groups. Scientific evidence suggests the importance of monitoring symptoms following acute infection, with a significant number of patients experiencing neurological complications even after recovery.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Medicine, General & Internal

Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data

Francesca Salamanna et al.

Summary: A substantial proportion of COVID-19 patients experience long-term symptoms after recovery, including abnormal lung functions, neurologic complaints, olfactory dysfunctions, chronic fatigue, and pain. Despite the heterogeneity in studies, findings highlight the presence of a post-COVID syndrome in a noteworthy proportion of patients who have suffered from SARS-CoV-2 infection.

FRONTIERS IN MEDICINE (2021)

Article Infectious Diseases

The health-related quality of life in Iranian patients with COVID-19

Cyrus Alinia et al.

Summary: COVID-19 significantly reduces patients' Health-Related Quality of Life (HRQoL), with factors like age, place of residence, and hospitalization status playing a key role in determining the impact.

BMC INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia

Yassine Souilmi et al.

Summary: Evolutionary analyses of human genomic datasets have revealed adaptive events involving coronaviruses and other viruses that likely occurred over 20,000 years ago in the ancestors of East Asian populations. The study highlights the importance of evolutionary information in predicting future pandemics, pointing to East Asia as a geographical origin of modern coronavirus epidemics and emphasizing that adaptation to ancient viral pressures in specific human populations does not imply genetic susceptibility differences.

CURRENT BIOLOGY (2021)

Review Clinical Neurology

Cognitive Impairment After COVID-19-A Review on Objective Test Data

Rania Daroische et al.

Summary: A literature review revealed that patients post COVID-19 may experience global cognitive impairment, memory difficulties, attention and executive function impairment, and verbal fluency issues. It is recommended that clinicians evaluate the need for cognitive assessment in patients with recent COVID-19 infection, and further studies are needed to investigate the condition.

FRONTIERS IN NEUROLOGY (2021)

Article Medicine, General & Internal

Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge

Modesto M. Maestre-Muniz et al.

Summary: The study investigated post-acute health consequences and mortality one year after hospital discharge among survivors of acute COVID-19. The findings revealed a 7.5% mortality rate among survivors and a significant proportion experiencing ongoing symptoms 1 year after disease onset.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms

Andreas Rank et al.

Summary: This study found that some patients with mild COVID-19 may still experience persistent symptoms one year later, but these symptoms gradually decrease over time. Specific antibodies can still be detected 12 months later, with antibody levels decreasing within the first 6 months but remaining stable up to 12 months.

JOURNAL OF CLINICAL MEDICINE (2021)

Letter Medicine, General & Internal

Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis

Marion Renaud et al.

Summary: This cohort study examines the clinical course and prognosis of patients with COVID-19-related anosmia for 1 year after diagnosis.

JAMA NETWORK OPEN (2021)

Article Infectious Diseases

Significance and Associated Factors of Long-Term Sequelae in Patients after Acute COVID-19 Infection in Korea

Yoonjung Kim et al.

Summary: The study found that the rate of COVID-19-related long-term sequelae was 65.7%, with the most common sequelae being fatigue. Female gender was identified as a factor associated with mental and psychological long-term sequelae.

INFECTION AND CHEMOTHERAPY (2021)

Article Medicine, General & Internal

Cognitive deficits in people who have recovered from COVID-19

Adam Hampshire et al.

Summary: This study investigates cognitive deficits in individuals who have recovered from COVID-19, showing that even asymptomatic individuals exhibit significant cognitive impairments. This suggests a multi-domain impact of COVID-19 on human cognition.

ECLINICALMEDICINE (2021)

Article Medicine, General & Internal

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis et al.

Summary: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.

ECLINICALMEDICINE (2021)

Letter Health Care Sciences & Services

Anosmia as a predictor for post-COVID-19 fatigue syndrome

Peter Wostyn

LANCET REGIONAL HEALTH-EUROPE (2021)

Article Health Care Sciences & Services

Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study

Max Augustin et al.

Summary: The study observed long-term symptoms in non-hospitalised patients post SARS-CoV-2 infection for four and seven months, identifying persistent symptoms such as shortness of breath, anosmia, ageusia, and fatigue, summarised as post-COVID syndrome (PCS).

LANCET REGIONAL HEALTH-EUROPE (2021)

Editorial Material Clinical Neurology

SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration

Alice Lippi et al.

MOVEMENT DISORDERS (2020)

Editorial Material Public, Environmental & Occupational Health

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020

Mark W. Tenforde et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Medicine, General & Internal

Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge

Limei Liang et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2020)

Article Otorhinolaryngology

Prognostic Factors of Olfactory Dysfunction

Thomas Hummel et al.

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2010)